APA Alıntı

Glesby, M. J., Albu, J., Chiu, Y., Ham, K., Engelson, E., He, Q., . . . Kotler, D. P. (2013). Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients with Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial. Public Library of Science.

Chicago Stili Alıntı

Glesby, Marshall J., et al. Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients With Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial. Public Library of Science, 2013.

MLA Alıntı

Glesby, Marshall J., et al. Recombinant Human Growth Hormone and Rosiglitazone for Abdominal Fat Accumulation in HIV-Infected Patients With Insulin Resistance: A Randomized, Double-Blind, Placebo-Controlled, Factorial Trial. Public Library of Science, 2013.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..